Viewing Study NCT04860518


Ignite Creation Date: 2025-12-25 @ 4:32 AM
Ignite Modification Date: 2025-12-26 @ 3:34 AM
Study NCT ID: NCT04860518
Status: TERMINATED
Last Update Posted: 2023-07-21
First Post: 2021-04-22
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Human Intravenous Interferon Beta-Ia Safety and Preliminary Efficacy in Hospitalized Subjects With COVID-19
Sponsor: Faron Pharmaceuticals Ltd
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-08-23
Start Date Type: ACTUAL
Primary Completion Date: 2022-04-04
Primary Completion Date Type: ACTUAL
Completion Date: 2022-04-04
Completion Date Type: ACTUAL
First Submit Date: 2021-04-22
First Submit QC Date: None
Study First Post Date: 2021-04-27
Study First Post Date Type: ACTUAL
Results First Submit Date: 2022-09-12
Results First Submit QC Date: None
Results First Post Date: 2022-10-14
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-07-03
Last Update Post Date: 2023-07-21
Last Update Post Date Type: ACTUAL